All News

I have to admit I think about death a lot more since my two cancers, and I think that is OK.

When senior citizens gather to discuss our latest medical interventions, procedures and replacement parts - there's just one way to describe it.

From plans to sue the School District of Philadelphia over a mesothelioma diagnosis to Dwayne “The Rock” Johnson singing for a 3-year-old with acute lymphoblastic leukemia, here’s what is making headlines in the cancer space this week.

The V Foundation for Cancer Research, a top-rated cancer research charity, is excited to announce Olympic Gold Medalist Scott Hamilton will return to the ice on November 24 at Bridgestone Arena in Nashville, TN for the fourth annual ‘Scott Hamilton & Friends.'

Know your cancer before making a treatment decision.

In partnership with the Australian Therapeutic Goods Administration (TGA) and Health Canada, the Food and Drug Administration (FDA) has granted supplemental approval to Calquence (acalabrutinib) for the treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

The art of camouflage can be important for the breast cancer survivor choosing not to reconstruct.

While radiation therapy may be a common alternative for inoperable hepatocellular carcinoma, two new studies suggest that proton radiation therapy may offer the same benefits as the more traditionally used photon radiation therapy, with less toxicity.

Nearly one-quarter of inoperable intrahepatic cholangiocarcinomas shrank enough to make surgery possible after selective internal radiation was added to chemotherapy, a study shows.

Having always thought of myself as someone who could handle anything, I learned that I didn’t have to do this on my own. Accepting help was okay

Both men and women have seen an increase in liver cancer diagnoses and death over the past nearly 20 years, according to new study findings.

Recent study findings showed that cervical cancer screening rates declined between ages 45 and 65, even as experts advise that women be screened through their lifetime.

“Live all you can, it’s a mistake not to. It doesn’t matter so much what you do in particular, so long as you have your life. If you haven’t had that, what have you had?”

Palliative care can make a huge difference for patients with cancer. Find out if it’s right for you.

After one woman’s father received a terminal stomach cancer diagnosis, she turned to Debbie’s Dream Foundation: Curing Stomach Cancer for information and guidance.

November is Stomach Cancer Awareness Month. Here's a round up of the latest news and updates in this disease space.

You never expect to get a diagnosis of cancer, but what about when it comes back?

While resistance can often make it a challenge to treat mantle cell lymphoma, therapies have come a long way in recent years thanks to the emergence of personalized treatment and the use of BTK inhibitors, according to one expert.

Pancreatic cancer doctors and researchers share what motivates them to do better for pancreatic cancer patients.

Researchers are expanding a clinical trial to include more patients with mantle cell lymphoma after some patients given the combination of medications under investigation showed no signs of cancer after treatment.

Clinical genetics experts see value in testing more women for BRCA mutations.

A two-time, nine-year cancer survivor offers some suggestions to newly diagnosed cancer survivors.

For National Family Caregivers Month, here’s a round-up of the latest news and updates that focus on the friends and family members that take up the role of caregiver when their loved ones need them most.

Think you're in control of your healthcare team? A recent experience reminded this patient that though it's her body, others may not consider her in charge of its care.

From the latest report on the “State of Lung Cancer” to NASA-style workouts for patients with cancer, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration has approved Brukinsa to treat patients with mantle cell lymphoma whose disease has stopped responding to other medications or has recurred.